Yang Yao

3.8k total citations
125 papers, 2.4k citations indexed

About

Yang Yao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yang Yao has authored 125 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 74 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Yang Yao's work include Sarcoma Diagnosis and Treatment (49 papers), Lung Cancer Treatments and Mutations (17 papers) and Colorectal Cancer Treatments and Studies (13 papers). Yang Yao is often cited by papers focused on Sarcoma Diagnosis and Treatment (49 papers), Lung Cancer Treatments and Mutations (17 papers) and Colorectal Cancer Treatments and Studies (13 papers). Yang Yao collaborates with scholars based in China, United States and Japan. Yang Yao's co-authors include Zan Shen, Wei‐Xiang Qi, Lina Tang, Aina He, Yuanjue Sun, Feng Lin, Daliu Min, Jingwen Wang, Yujing Huang and Hui Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yang Yao

120 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Yao China 29 1.2k 1.1k 694 333 302 125 2.4k
Wei‐Xiang Qi China 24 1.1k 1.0× 940 0.9× 426 0.6× 391 1.2× 227 0.8× 109 2.1k
Lina Tang China 23 831 0.7× 645 0.6× 446 0.6× 150 0.5× 171 0.6× 73 1.6k
Roberto Petrioli Italy 28 1.6k 1.4× 1.2k 1.1× 508 0.7× 855 2.6× 407 1.3× 135 3.1k
Theofanis Economopoulos Greece 36 1.6k 1.3× 651 0.6× 990 1.4× 704 2.1× 328 1.1× 124 4.0k
Hiroyuki Yasuda Japan 31 1.3k 1.1× 1.6k 1.5× 983 1.4× 765 2.3× 461 1.5× 133 3.0k
Thierry Alcindor Canada 18 1.3k 1.1× 1.3k 1.2× 422 0.6× 455 1.4× 141 0.5× 85 2.4k
Sri Harsha Tella United States 23 967 0.8× 414 0.4× 818 1.2× 658 2.0× 287 1.0× 95 2.5k
Lars M. Wagner United States 29 707 0.6× 845 0.8× 1.1k 1.6× 237 0.7× 386 1.3× 82 2.4k
P Soulié France 25 1.7k 1.4× 761 0.7× 369 0.5× 239 0.7× 394 1.3× 118 2.3k
Narihide Goseki Japan 17 1.0k 0.9× 792 0.7× 426 0.6× 1.0k 3.1× 282 0.9× 80 2.6k

Countries citing papers authored by Yang Yao

Since Specialization
Citations

This map shows the geographic impact of Yang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Yao more than expected).

Fields of papers citing papers by Yang Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Yao. The network helps show where Yang Yao may publish in the future.

Co-authorship network of co-authors of Yang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Yao. A scholar is included among the top collaborators of Yang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Yao. Yang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yawen, Yong Liu, Xipeng Sun, et al.. (2022). Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway. Frontiers in Oncology. 12. 842406–842406. 12 indexed citations
2.
Yuan, Yuan, et al.. (2019). MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen. International Journal of Oncology. 54(6). 2019–2029. 9 indexed citations
3.
Zhang, Jianjun, Yujing Huang, Jing Lu, et al.. (2018). Impact of first-line treatment on outcomes of Ewing sarcoma of the spine.. PubMed. 8(7). 1262–1272. 14 indexed citations
4.
Zhang, Jianjun, Yan Zhou, Kun Han, et al.. (2016). Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA‐221. Evidence-based Complementary and Alternative Medicine. 2016(1). 7319464–7319464. 18 indexed citations
5.
Sun, Yuanjue, Yongqian Shu, Baorui Liu, et al.. (2016). A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy. Experimental and Therapeutic Medicine. 12(6). 4017–4024. 19 indexed citations
6.
Chi, Yihebali, Yongkun Sun, Jianqiang Cai, et al.. (2016). Phase II study of anlotinib for treatment of advanced soft tissues sarcomas.. Journal of Clinical Oncology. 34(15_suppl). 11005–11005. 21 indexed citations
7.
Gan, Zhihua, Shuchen Lin, Kun Han, et al.. (2015). Bilateral spontaneous pneumothorax in an osteosarcoma patient with pulmonary metastases: A case report. Oncology Letters. 11(2). 1179–1180. 6 indexed citations
8.
Zheng, Shuier, Guanglei Qiao, Daliu Min, et al.. (2015). Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma. Cancer Letters. 359(1). 36–46. 31 indexed citations
9.
Qi, Wei‐Xiang, Qiong Wang, Yanling Jiang, et al.. (2013). Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data. PLoS ONE. 8(2). e55637–e55637. 28 indexed citations
10.
Hu, Haiyan, Yuan Liu, Tao Feng, et al.. (2013). Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter. Cell Biology International. 38(5). 563–570. 38 indexed citations
11.
Qi, Wei‐Xiang, Lina Tang, Yaping Sun, et al.. (2013). Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials. Annals of Oncology. 24(12). 2943–2952. 37 indexed citations
12.
Han, Kun, Wei‐Xiang Qi, Zhihua Gan, et al.. (2013). Prognostic Value of Ezrin in Solid Tumors: A Meta-Analysis of the Literature. PLoS ONE. 8(7). e68527–e68527. 8 indexed citations
13.
Yao, Yang. (2012). Clinical significances of Runx2 and Ezrin expressions in osteosarcoma. Zhongguo aizheng zazhi. 2 indexed citations
14.
Feng, Lin, et al.. (2012). Magnesium isoglycyrrhizinate used in the treatment of chemotherapeutic drugs-induced acute liver dysfunction: A phase III clinical trial. Tumori. 32(9). 738–743. 8 indexed citations
15.
He, Aina, Wei‐Xiang Qi, Yujing Huang, et al.. (2012). CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study. Experimental and Therapeutic Medicine. 4(3). 435–441. 41 indexed citations
16.
Han, Kun, Yuanjue Sun, Jianjun Zhang, et al.. (2012). Retrospective clinical analysis of MAID protocol as first-line treatment on 137 metastatic soft-tissue sarcomas patients. The Chinese-German Journal of Clinical Oncology. 11(2). 117–120. 1 indexed citations
17.
Wang, Zhiyu, Chun-Gen Wu, Hongtao Li, et al.. (2012). CT Fluoroscopy-guided Percutaneous Osteoplasty for the Treatment of Osteolytic Lung Cancer Bone Metastases to the Spine and Pelvis. Journal of Vascular and Interventional Radiology. 23(9). 1135–1142. 24 indexed citations
18.
Qi, Wei‐Xiang, Zan Shen, & Yang Yao. (2011). Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials. Journal of Cancer Research and Clinical Oncology. 137(12). 1785–1790. 17 indexed citations
19.
Lin, Feng, et al.. (2009). Survival analysis of 71 cases of osteosarcoma with lung metastases. Tumori. 29(5). 471–474. 1 indexed citations
20.
Yao, Yang. (2007). Correlation between serum AKP and prognosis of osteosarcoma(with 69 osteosarcoma cases). Zhongguo aizheng zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Xiang Qi Breakdown of academic impact, for papers by Lina Tang Breakdown of academic impact, for papers by Roberto Petrioli Breakdown of academic impact, for papers by Theofanis Economopoulos Breakdown of academic impact, for papers by Hiroyuki Yasuda Breakdown of academic impact, for papers by Thierry Alcindor Breakdown of academic impact, for papers by Sri Harsha Tella Breakdown of academic impact, for papers by Lars M. Wagner Breakdown of academic impact, for papers by P Soulié Breakdown of academic impact, for papers by Narihide Goseki
Rankless by CCL
2026